CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

New evidence supports ivermectin use in children weighing less than fifteen kilograms

Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication.

18 Mar 2021

Study of post-acute sequelae of SARS-CoV-2 infection shows persistent symptoms 8 months

Researchers from the US recently studied the prevalence of PASC in a well-characterized cohort of patients to gain insights into the period following acute SARS-CoV-2 infection. The research is posted online to the preprint server medRxiv.

15 Mar 2021

WHA’s president outlines plans to improve treatments for patients with hepatitis

Danjuma Adda, a Nigerian public health expert, became the president-elect of the World Hepatitis Alliance (WHA) in November last year. He is the first African to hold the position.

15 Mar 2021

Mass immunization to stop Ebola outbreak in Guinea

As the first shipment of COVID-19 vaccines arrived in Africa this week, another vaccine was being rolled out in Guinea, in a bid to stop a fresh outbreak of Ebola in its tracks.

10 Mar 2021

Texas winter storm exposes gaps in senior living oversight

When the big, red and extremely loud fire alarm went off in Maria Skladzien's apartment, the 74-year-old ventured into the hallway with fellow residents of her Houston-area senior living community.

10 Mar 2021

California’s vaccine appointment website has glitches. No surprise?

California rolled out a statewide covid vaccination website this week aiming to streamline the appointment process after months of criticism, but the site is riddled with its own snags, preventing many from signing up for shots.

5 Mar 2021

IQWiG's new threshold proven feasible in practice for early benefit assessments of drugs

Current examples prove the feasibility of the 15 percent threshold newly defined by IQWiG for the acceptance of responder analyses in early benefit assessments of drugs.

5 Mar 2021

Readers and tweeters dispense timely advice for difficult times

Your body’s immune system has produced antibodies that will kill a few thousand kinds of germs and virus. Since you are alive, the chances are quite high you will survive its producing another. Here is how the system works.

2 Mar 2021

Borosilicate Glass Microplates Improve Imaging Sensitivity

Porvair Sciences new Krystal™ Glass Bottom microplate with high quality specialty glass from Schott provides unmatched performance for whole-plate CCD imaging and laser detection applications.

From Chromatrap® - Porvair Sciences Ltd 26 Feb 2021

New report identifies key barriers and enablers for data sharing in dementia research

At an online European Parliament workshop hosted by Deirdre Clune MEP (Ireland), Alzheimer Europe launched a new report "Data Sharing in Dementia Research", which reviews recent changes in EU research policy and sets out recommendations to improve data sharing in dementia research.

23 Feb 2021

Taking Advantage of Measuring Molecular Collisional Cross-Sections in Pharma

News-Medical talks to Mike Greig, Director of Pharma at Bruker, about why measuring collisional cross-sections is beneficial to developing new drugs.

From Bruker Daltonics 10 Feb 2021

UiB professor receives 12 million NOK to study the relation between psychosis and criminal insanity

How and why does psychosis play a role when defining someone as criminally insane and lacking capacity for responsible action? Professor Linda Gröning at The Faculty of Law has been given 12 million NOK from The Research Council of Norway to learn more about the nuances of this question.

6 Feb 2021

New COVID-19 variant identified in Brazilian Amazon spreads faster

A new variant of the virus that causes COVID-19, identified in Brazil, is likely more transmissible than its parent strain because of mutations in the spike protein, according to researchers.

1 Feb 2021

As vaccine rollout expands, Black Americans still left behind

Black Americans are still receiving covid vaccinations at dramatically lower rates than white Americans even as the chaotic rollout reaches more people, according to a new KHN analysis.

29 Jan 2021

Prioritizing older adults for COVID-19 vaccination will save more lives

Vaccinating older adults for COVID-19 first will save substantially more U.S. lives than prioritizing other age groups, and the slower the vaccine rollout and more widespread the virus, the more critical it is to bring them to the front of the line.

21 Jan 2021

Expert urges to stop 5G networks until people’s safety is confirmed

We should err on the side of caution and stop the global roll out of 5G (fifth generation) telecoms networks until we are certain this technology is completely safe, urges an expert in an opinion piece published online in the Journal of Epidemiology & Community Health.

19 Jan 2021

Personalized neuromodulation approach provides relief from severe depression symptoms

Targeted neuromodulation tailored to individual patients' distinctive symptoms is an increasingly common way of correcting misfiring brain circuits in people with epilepsy or Parkinson's disease.

18 Jan 2021

New tests may help improve the selection of men considering prostate cancer surveillance

Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.

15 Jan 2021

Study offers a differentiated patient-specific solution in minimal residual disease testing

Exact Sciences Corp. today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

15 Jan 2021

Researchers develop a low-cost, saliva-optimized RT-LAMP assay for faster detection of SARS-CoV-2

SARS-CoV-2 pandemic has highlighted the shortcomings in emergency response globally and has driven a massive demand for in vitro diagnostic testing technologies. In order to address these issues, researchers from the US recently used the new pH dye LAMPShade Violet (LSV) in RT-LAMP. LSV has better visual contrast between high and low pH and a stronger inflection point, both of which enable easy interpretation of results and reduces ambiguity.

8 Jan 2021

CLARITY News and Research

Further Reading

New evidence supports ivermectin use in children weighing less than fifteen kilograms

Study of post-acute sequelae of SARS-CoV-2 infection shows persistent symptoms 8 months

WHA’s president outlines plans to improve treatments for patients with hepatitis

Mass immunization to stop Ebola outbreak in Guinea

Texas winter storm exposes gaps in senior living oversight

California’s vaccine appointment website has glitches. No surprise?

IQWiG's new threshold proven feasible in practice for early benefit assessments of drugs

Readers and tweeters dispense timely advice for difficult times

Borosilicate Glass Microplates Improve Imaging Sensitivity

New report identifies key barriers and enablers for data sharing in dementia research

Taking Advantage of Measuring Molecular Collisional Cross-Sections in Pharma

UiB professor receives 12 million NOK to study the relation between psychosis and criminal insanity

New COVID-19 variant identified in Brazilian Amazon spreads faster

As vaccine rollout expands, Black Americans still left behind

Prioritizing older adults for COVID-19 vaccination will save more lives

Expert urges to stop 5G networks until people’s safety is confirmed

Personalized neuromodulation approach provides relief from severe depression symptoms

New tests may help improve the selection of men considering prostate cancer surveillance

Study offers a differentiated patient-specific solution in minimal residual disease testing

Researchers develop a low-cost, saliva-optimized RT-LAMP assay for faster detection of SARS-CoV-2

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

New horizons in drug discovery: High-throughput & target-to-therapy advances

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology